Study to Assess the Safety, Tolerability, Pharmacokinetic of Thrv-1268
NCT06507839
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Atrial Fibrillation
Interventions
DRUG:
THRV-1268
OTHER:
Placebo
Sponsor
Thryv Therapeutics, Inc.